- CLINICAL BRIEFINGS
Through comprehensive genomic and immune analyses, mechanisms of lung cancer resistance after treatment with EGFR inhibition and vaccine therapy were investigated. This case report, together with data from the longitudinal lung cancer study TRACERx, highlight the importance of understanding when targeted variants are acquired during the cancer’s evolutionary history.
You Might Also Like
What happens if pregnant women stop taking Tylenol?
There are limited options for pain relief during pregnancy.Credit: The Good Brigade/GettyResearchers are concerned about what will happen should pregnant...
Engineered enzymes can suppress genome-editing errors
RESEARCH BRIEFINGS 24 September 2025 Genome editors are molecular machines that can rewrite the genetic code in cells, but sometimes...
Hotly anticipated US vaccine meeting ends with confusion — and a few decisions
A US vaccine advisory panel decided Friday not to require prescriptions for COVID-19 vaccinations Credit: Spencer Platt/GettyAn influential panel of...
Can AI chatbots trigger psychosis? What the science says
Chatbots give positive, human-like responses to prompts from users.Credit: Jaap Arriens/NurPhoto via GettyAccounts of people developing psychosis — which renders...